ImmunOs Therapeutics
Basel, Switzerland · Founded 2014 · $102.5M raised
- Headquarters
- Basel
- Employees
- 11–50
- Founded
- 2014
- Business Model
- B2B
- Website
- immunostherapeutics.com
- Total Funding
- $102.5M
- Last Round
- $11.0M Series CSep 2024
- Rounds
- 3
About
Swiss biotech developing novel human immunomodulatory proteins for cancer treatment, focused on innate immunity.
Summary
ImmunOs Therapeutics is a Biotech company based in Basel, Switzerland, founded in 2014. It has raised $102.5M in total across 3 rounds, most recently a $11.0M Series C round in Sep 2024. Investors include Lightspeed VP, Gimv and Pfizer Ventures.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2024
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.